UNSPSC 51271620: Eutectic mixture of local anesthetics

This classification denotes an anesthetic combination drug with the molecular formula C27H42N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 046O35D44R-98PI200987, chemically known as 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;N-(2-methylphenyl)-2-(propylamino)propanamide but generally known as emla or eutectic mixture of local anesthetics, which bears US NIH Compound Identifier 9911821.

SMILES:CCCNC(C)C(=O)NC1=CC=CC=C1C.CCN(CC)CC(=O)NC1=C(C=CC=C1C)C. Eutectic mixture of local anesthetics bears US NLM identifiers UMLS ID C0059079 and NCI Concept Code C1081.

UNSPSC 51271620 Eutectic mixture of local anesthetics, a Commodity code, covers a specific pharmaceutical preparation used in clinical and procedural settings by state and local health systems, correctional departments, emergency services, and dental programs. State and local buyers procure this product — typically a cream or patch containing a eutectic blend of lidocaine and prilocaine (EMLA) or equivalent formulations — for topical anesthesia during minor procedures, vaccinations, blood draws, and dermatological treatments. Purchase volumes and frequencies vary by institution type; large health systems and correctional facilities with high-volume procedural caseloads tend to be steady buyers, while smaller clinics and school-based health centers purchase as needed.

The recent state and local opportunities block provided no records, indicating limited or no recent procurement activity logged under this code in the sources reviewed. State and local procurement offices may apply related pharmaceutical codes or purchase EMLA through standing state contracts, group purchasing organizations, or pharmaceutical cooperative agreements rather than issuing discrete solicitations by this specific commodity code. Firms pursuing this code should confirm current demand through direct outreach to state health departments, corrections agencies, and larger municipal health systems; activity may be concentrated in jurisdictions with large correctional or emergency-services caseloads rather than distributed across many issuing bodies.